Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,600.00
Bid: 1,598.00
Ask: 1,598.50
Change: -4.50 (-0.28%)
Spread: 0.50 (0.031%)
Open: 1,613.00
High: 1,613.00
Low: 1,589.00
Prev. Close: 1,604.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks trim losses on Greek hopes, Chinese stimulus

Wed, 04th Feb 2015 17:09

A late rally helped the FTSE 100 to erase most of its losses on Wednesday as optimism surrounding Greece and stimulus measures in China lifted sentiment, though stocks still finished in the red after hitting a five-month high the previous day.London's Footsie ended the session down 0.2% at 6,860.02, bouncing strongly in the last couple of hours after hitting an intraday low of 6,804.10, with pharma heavyweight Glaxosmithkline rising after its results announcement.Greece's prime minister Alexis Tsipras said in a press conference that he believes a debt relief deal can be met without the country leaving the EU. Tsipras said despite not having a deal yet, the country is "moving in the right direction".The prime minister travelled to Brussels to propose the new government's debt-swap plan to EU Commission president Jean-Claude Juncker. Greece has backed down from calling for a total debt write-off and has instead proposed swapping outstanding debt for new growth-linked bonds.Meanwhile, Greek finance minister Yanis Varoufakis, who held a meeting in Frankfurt with European Central Bank head Mario Draghi, said that discussions about easing the terms of the country's bailout were "very fruitful".Elsewhere, the People's Bank of China (PBoC) trimmed the banks' reserve requirement ratio by 50 basis points to 19.5%, the first such cut since May 2012, in an effort to boost lending into the real economy.According to FXTM analyst Jameel Ahmad, the PBoC was the 16th central bank across the globe to ease monetary policy this year in a move that "will be seen by many as a direct response to continued indications of slowing domestic momentum". He said the cut in the reserve requirement will be judged "by the markets as a positive move to reinvigorate economic growth".A raft of service-sector data was released during Wednesday session, showing that growth had picked up in the UK, Eurozone and US but eased in China.Glaxo leads late rallySales, profits and earnings slumped during the last quarter of the year at drugmaker GlaxoSmithKline due to headwinds in the US market, though the company pleased investors after confirming it would return £4bn cash from its deal with Novartis.Others in the pharma sector was also in demand, such as Astrazeneca, Hikma and Synergy Health with the latter benefiting after reporting a solid acceleration in underlying revenue growth in its third quarter.In its first set of results since slimming down its name to Sky and absorbing its German and Italian sister companies, the satellite broadcaster delivered a strong set of interim figures and cited good momentum in all its markets, causing shares to rise.Half-yearly results from fund manager and savings outfit Hargreaves Lansdown showed record assets under administration and growing client numbers, though shares fell sharply after revenues and profits came in shy of City expectations.Oil stocks were stuck in the red as the recent rally in crude prices came to an end with Brent falling 2.9%. Shell, Tullow, Afren and BHP Billiton all declined. Market MoverstechMARK 3,083.09 +0.68%FTSE 100 6,860.02 -0.17%FTSE 250 16,571.64 +0.01%FTSE 100 - RisersITV (ITV) 230.60p +3.64%ARM Holdings (ARM) 1,069.00p +3.09%easyJet (EZJ) 1,778.00p +2.72%Wolseley (WOS) 3,888.00p +1.94%CRH (CRH) 1,779.00p +1.89%Barratt Developments (BDEV) 470.00p +1.78%GlaxoSmithKline (GSK) 1,476.00p +1.58%Ashtead Group (AHT) 1,079.00p +1.41%Burberry Group (BRBY) 1,796.00p +1.41%International Consolidated Airlines Group SA (CDI) (IAG) 542.00p +1.40%FTSE 100 - FallersHargreaves Lansdown (HL.) 966.00p -7.56%Tullow Oil (TLW) 395.90p -5.15%Morrison (Wm) Supermarkets (MRW) 181.50p -2.42%Sainsbury (J) (SBRY) 266.70p -2.16%BHP Billiton (BLT) 1,527.00p -2.02%Aggreko (AGK) 1,596.00p -1.84%Anglo American (AAL) 1,150.00p -1.71%BG Group (BG.) 932.00p -1.38%Intertek Group (ITRK) 2,398.00p -1.28%SABMiller (SAB) 3,528.50p -1.27%FTSE 250 - RisersRank Group (RNK) 185.50p +4.80%Petra Diamonds Ltd.(DI) (PDL) 158.20p +4.42%AO World (AO.) 319.50p +4.28%Booker Group (BOK) 153.50p +3.44%Brown (N.) Group (BWNG) 448.60p +3.08%AL Noor Hospitals Group (ANH) 927.50p +3.00%Countrywide (CWD) 496.80p +2.88%Lonmin (LMI) 172.30p +2.62%Ultra Electronics Holdings (ULE) 1,778.00p +2.48%Howden Joinery Group (HWDN) 425.10p +2.46%FTSE 250 - FallersAfren (AFR) 11.10p -6.25%Premier Oil (PMO) 161.10p -5.79%Hunting (HTG) 456.20p -4.70%Wood Group (John) (WG.) 596.00p -4.03%Aveva Group (AVV) 1,390.00p -3.67%Ladbrokes (LAD) 120.10p -3.15%Thomas Cook Group (TCG) 126.10p -3.00%Interserve (IRV) 541.50p -2.96%Diploma (DPLM) 755.50p -2.58%Petrofac Ltd. (PFC) 742.50p -2.24%
More News
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
11 Oct 2023 07:47

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

Read more
9 Oct 2023 08:16

TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine

(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.